Cargando…
Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices
BACKGROUND: Developmental disorders (DD), including autism spectrum disorder (ASD) and intellectual disability (ID), are a common group of clinical manifestations caused by a variety of genetic abnormalities. Genetic testing, including chromosomal microarray (CMA), plays an important role in diagnos...
Autores principales: | Peabody, John, Martin, Megan, DeMaria, Lisa, Florentino, Jhiedon, Paculdo, David, Paul, Michael, Vanzo, Rena, Wassman, E. Robert, Burgon, Trever |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5201278/ https://www.ncbi.nlm.nih.gov/pubmed/28036350 http://dx.doi.org/10.1371/journal.pone.0169064 |
Ejemplares similares
-
Improving Clinical Practice Using a Novel Engagement Approach: Measurement, Benchmarking and Feedback, A Longitudinal Study
por: Peabody, John W., et al.
Publicado: (2016) -
Low Rates of Genetic Testing in Children With Developmental Delays, Intellectual Disability, and Autism Spectrum Disorders
por: Peabody, John, et al.
Publicado: (2015) -
Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial
por: Peabody, John W., et al.
Publicado: (2017) -
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
por: Peabody, John, et al.
Publicado: (2020) -
Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
por: Peabody, John, et al.
Publicado: (2019)